WebRequest is for Reclast® for one of the following indications (a,b,c,d,or e): a. Treatment of osteoporosis in postmenopausal woman and one of the following (i or ii): ... • HCPCS – J3489 REFERENCES / FOOTNOTES: 1. Reclast [package insert]. East Hanover, NJ; Novartis Pharmaceuticals; April 2024. Accessed December 2024. Web8 rows · Reclast ® HCPCS code J3489 (Injection, zoledronic acid 1 mg) should be used to report Reclast ®. · The number of units billed on a claim should be 5, since Relcast ® is …
Zoledronic acid (Reclast®) - AHA Coding Clinic® for HCPCS
WebJ3488 Injection, zoledronic acid (reclast), 1 mg HCPCS Code J3488 The Healthcare Common Prodecure Coding System (HCPCS) is a collection of codes that represent procedures, supplies, products and services which may be provided to Medicare beneficiaries and to individuals enrolled in private health insurance programs.The codes … WebZoledronic acid (Reclast® and Zometa®) is a bisphosphonic acid, which is an inhibitor of osteoclastic bone resorption. Zoledronic acid binds to the bone matrix, which decreases … introduction\u0027s xk
Zoledronic acid (Reclast®) - AHA Coding Clinic® for …
WebMar 27, 2024 · Prolia (denosumab) and Reclast (zoledronic acid) are injections that can be used to treat or prevent osteoporosis in postmenopausal women. But they each work differently because Prolia is a monoclonal antibody (it may also be called a miscellaneous bone resorption agent) and Reclast is a bisphosphonate which means they have … WebOct 1, 2015 · Zoledronic acid injection (Reclast®) ... diagnosis code range M80.00XA-M80.88XS to the “ICD-10 Codes that Support Medical Necessity” section of the LCD for … WebJan 1, 2024 · Prior authorization required 19300 19316 19318 19325 19328 19330 19340 19342 19350 19357 19361 19364 19367 19368 19369 19370 19371 19380 19396 L8600 new outlook financial